Home

Recent Articles from StockStory

StockStory is a financial technology company dedicated to simplifying profitable stock investing for individual investors. By leveraging advanced AI technology and human expertise, it generates detailed, data-driven research reports and monthly stock picks to identify high-quality stocks with strong growth potential. The company aims to democratize access to sophisticated analytical methods and proprietary datasets—previously exclusive to elite hedge funds—delivering clear, actionable insights rather than complex, do-it-yourself tools. With a mission to level the playing field in a market often favoring large institutions, StockStory provides retail investors with the resources to make informed, market-beating investment decisions.

3 Growth Stocks to Add to Your Roster
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
Via StockStory · November 21, 2025
3 Consumer Stocks We Find Risky
The performance of consumer discretionary businesses is closely linked to economic cycles. Thankfully for the industry, demand trends seem to be healthy as discretionary stocks have gained 10.9% over the past six months. This performance has nearly mirrored the S&P 500.
Via StockStory · November 21, 2025
1 Consumer Stock with Promising Prospects and 2 Facing Headwinds
Most consumer discretionary businesses succeed or fail based on the broader economy. Lately, it seems like demand trends have worked in their favor as the industry has returned 10.9% over the past six months, similar to the S&P 500.
Via StockStory · November 21, 2025
3 Russell 2000 Stocks with Questionable Fundamentals
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Via StockStory · November 21, 2025
1 of Wall Street’s Favorite Stock on Our Buy List and 2 That Underwhelm
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Via StockStory · November 21, 2025
3 Stocks Under $10 Walking a Fine Line
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
Via StockStory · November 21, 2025
3 Russell 2000 Stocks We Steer Clear Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Via StockStory · November 21, 2025
3 Russell 2000 Stocks We’re Skeptical Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Via StockStory · November 21, 2025
ESTC Q3 Deep Dive: AI Adoption, Platform Consolidation, and Large Deals Drive Results
Search AI platform provider Elastic (NYSE:ESTC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 15.9% year on year to $423.5 million. Guidance for next quarter’s revenue was optimistic at $438 million at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.64 per share was 11.1% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
BBWI Q3 Deep Dive: Strategic Reset Drives Transformation Amid Weak Consumer Demand
Personal care and home fragrance retailer Bath & Body Works (NYSE:BBWI) missed Wall Street’s revenue expectations in Q3 CY2025, with sales flat year on year at $1.59 billion. Its GAAP profit of $0.37 per share was 5.1% below analysts’ consensus estimates.
Via StockStory · November 21, 2025
WMT Q3 Deep Dive: E-Commerce, International, and AI Power Walmart’s Momentum
Retail behemoth Walmart (NYSE:WMT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 5.8% year on year to $179.5 billion. Its non-GAAP profit of $0.62 per share was 3.2% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
J Q3 Deep Dive: Margin Expansion and Sector Pipeline Growth Offset Mixed Market Reaction
Global professional services company Jacobs Solutions (NYSE:J) announced better-than-expected revenue in Q3 CY2025, with sales up 6.6% year on year to $3.15 billion. Its non-GAAP profit of $1.75 per share was 4.2% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
ROAD Q3 Deep Dive: Acquisition-Driven Growth and Margin Expansion Amid Profitability Miss
Civil infrastructure company Construction Partners (NASDAQ:ROAD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 67.2% year on year to $899.8 million. The company’s full-year revenue guidance of $3.45 billion at the midpoint came in 0.8% above analysts’ estimates. Its GAAP profit of $1.01 per share was 8.3% below analysts’ consensus estimates.
Via StockStory · November 21, 2025
MMS Q3 CY2025 Deep Dive: Flat Revenue, Tech-Driven Margin Outlook, and Policy Tailwinds
Government services provider Maximus (NYSE:MMS) missed Wall Street’s revenue expectations in Q3 CY2025, with sales flat year on year at $1.32 billion. The company’s full-year revenue guidance of $5.33 billion at the midpoint came in 4.5% below analysts’ estimates. Its non-GAAP profit of $1.62 per share was 3% below analysts’ consensus estimates.
Via StockStory · November 21, 2025
GAP Q3 Deep Dive: Brand Reinvigoration and Product Momentum Drive Outperformance
Clothing and accessories retailer Gap (NYSE:GAP) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 3% year on year to $3.94 billion. Its GAAP profit of $0.62 per share was 5.6% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
INTU Q3 Deep Dive: AI Investments and Platform Expansion Drive Outperformance
Financial technology platform Intuit (NASDAQ:INTU) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 18.3% year on year to $3.89 billion. Guidance for next quarter’s revenue was better than expected at $4.53 billion at the midpoint, 1.3% above analysts’ estimates. Its non-GAAP profit of $3.34 per share was 8.1% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
ESE Q3 Deep Dive: Maritime Acquisition, Renewables Headwinds, and Backlog Shape Outlook
Engineered products manufacturer ESCO (NYSE:ESE) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 18.1% year on year to $352.7 million. The company’s full-year revenue guidance of $1.29 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 8.7% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
CPRT Q3 Deep Dive: Market Share Pressures Weigh Amid Mixed Insurance and Auction Trends
Online vehicle auction company Copart (NASDAQ:CPRT) fell short of the markets revenue expectations in Q3 CY2025, with sales flat year on year at $1.16 billion. Its GAAP profit of $0.41 per share was 3.5% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
WMG Q3 Deep Dive: Streaming Gains Offset Margin Compression, AI Licensing a Key Focus
Global music entertainment company Warner Music Group (NASDAQ:WMG) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 14.6% year on year to $1.87 billion. Its GAAP profit of $0.21 per share was 38.7% below analysts’ consensus estimates.
Via StockStory · November 21, 2025
ROST Q3 Deep Dive: Branded Strategy and Store Initiatives Fuel Broad-Based Growth
Off-price retail company Ross Stores (NASDAQ:ROST) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $5.60 billion. Its GAAP profit of $1.58 per share was 10.9% above analysts’ consensus estimates.
Via StockStory · November 21, 2025
1 S&P 500 Stock with Promising Prospects and 2 Facing Headwinds
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · November 21, 2025
1 Mid-Cap Stock to Target This Week and 2 Facing Headwinds
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
Via StockStory · November 20, 2025
1 Small-Cap Stock to Consider Right Now and 2 We Ignore
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Via StockStory · November 20, 2025
3 Stocks Under $10 with Warning Signs
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.
Via StockStory · November 20, 2025
1 Stock Under $50 with Solid Fundamentals and 2 Facing Challenges
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Via StockStory · November 20, 2025
3 Reasons to Sell WABC and 1 Stock to Buy Instead
Over the past six months, Westamerica Bancorporation’s shares (currently trading at $46.46) have posted a disappointing 5.5% loss, well below the S&P 500’s 13.7% gain. This may have investors wondering how to approach the situation.
Via StockStory · November 20, 2025
3 Big Reasons to Love Skyward Specialty Insurance (SKWD)
What a brutal six months it’s been for Skyward Specialty Insurance. The stock has dropped 24.7% and now trades at $46.60, rattling many shareholders. This might have investors contemplating their next move.
Via StockStory · November 20, 2025
3 Reasons to Sell PESI and 1 Stock to Buy Instead
Perma-Fix has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 10.8% to $11.25 per share while the index has gained 13.7%.
Via StockStory · November 20, 2025
3 Reasons to Avoid EXPD and 1 Stock to Buy Instead
Expeditors’s 22.7% return over the past six months has outpaced the S&P 500 by 9%, and its stock price has climbed to $139.22 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · November 20, 2025
3 Reasons to Sell LFST and 1 Stock to Buy Instead
LifeStance Health Group trades at $6.18 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 13.7%.
Via StockStory · November 20, 2025
BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, BioMarin Pharmaceutical’s stock price fell to $51.76. Shareholders have lost 11.5% of their capital, which is disappointing considering the S&P 500 has climbed by 13.7%. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · November 20, 2025
3 Reasons LGIH is Risky and 1 Stock to Buy Instead
Over the past six months, LGI Homes’s stock price fell to $44.28. Shareholders have lost 15.8% of their capital, which is disappointing considering the S&P 500 has climbed by 13.7%. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · November 20, 2025
3 Reasons ACHC is Risky and 1 Stock to Buy Instead
Shareholders of Acadia Healthcare would probably like to forget the past six months even happened. The stock has dropped 39.1% and now trades at a new 52-week low of $14.31. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · November 20, 2025
3 Reasons AFG is Risky and 1 Stock to Buy Instead
American Financial Group trades at $137.11 and has moved in lockstep with the market. Its shares have returned 11.6% over the last six months while the S&P 500 has gained 13.7%.
Via StockStory · November 20, 2025
3 Reasons to Avoid SNAP and 1 Stock to Buy Instead
Over the past six months, Snap’s shares (currently trading at $7.79) have posted a disappointing 6% loss, well below the S&P 500’s 13.7% gain. This may have investors wondering how to approach the situation.
Via StockStory · November 20, 2025
MarketAxess (MKTX): Buy, Sell, or Hold Post Q3 Earnings?
MarketAxess’s stock price has taken a beating over the past six months, shedding 26.6% of its value and falling to $161.19 per share. This may have investors wondering how to approach the situation.
Via StockStory · November 20, 2025
Charter (CHTR): Buy, Sell, or Hold Post Q3 Earnings?
Shareholders of Charter would probably like to forget the past six months even happened. The stock dropped 53.2% and now trades at $194.51. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · November 20, 2025
3 Reasons to Sell CVGI and 1 Stock to Buy Instead
Over the past six months, Commercial Vehicle Group has been a great trade, beating the S&P 500 by 5%. Its stock price has climbed to $1.56, representing a healthy 18.7% increase. This run-up might have investors contemplating their next move.
Via StockStory · November 20, 2025
3 Reasons We Love SouthState (SSB)
Since May 2025, SouthState has been in a holding pattern, posting a small loss of 2.4% while floating around $85.75. The stock also fell short of the S&P 500’s 13.7% gain during that period.
Via StockStory · November 20, 2025
3 Reasons PLUS is Risky and 1 Stock to Buy Instead
ePlus has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.4%. The stock now trades at $87.65, marking a 34% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · November 20, 2025
Reflecting On Casino Operator Stocks’ Q3 Earnings: Golden Entertainment (NASDAQ:GDEN)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the casino operator industry, including Golden Entertainment (NASDAQ:GDEN) and its peers.
Via StockStory · November 20, 2025
A Look Back at Casino Operator Stocks’ Q3 Earnings: MGM Resorts (NYSE:MGM) Vs The Rest Of The Pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how MGM Resorts (NYSE:MGM) and the rest of the casino operator stocks fared in Q3.
Via StockStory · November 20, 2025
Insurance Stocks Q3 Results: Benchmarking Kemper (NYSE:KMPR)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at insurance stocks, starting with Kemper (NYSE:KMPR).
Via StockStory · November 20, 2025
Q3 Earnings Highs And Lows: Inter Parfums (NASDAQ:IPAR) Vs The Rest Of The Personal Care Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Inter Parfums (NASDAQ:IPAR) and its peers.
Via StockStory · November 20, 2025
Regional Banks Stocks Q3 Results: Benchmarking Wintrust Financial (NASDAQ:WTFC)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Wintrust Financial (NASDAQ:WTFC) and its peers.
Via StockStory · November 20, 2025
Q3 Telecommunication Services Earnings Review: First Prize Goes to Iridium (NASDAQ:IRDM)
Let’s dig into the relative performance of Iridium (NASDAQ:IRDM) and its peers as we unravel the now-completed Q3 telecommunication services earnings season.
Via StockStory · November 20, 2025
Q3 Earnings Outperformers: Markel Group (NYSE:MKL) And The Rest Of The Property & Casualty Insurance Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Markel Group (NYSE:MKL) and the rest of the property & casualty insurance stocks fared in Q3.
Via StockStory · November 20, 2025
Spotting Winners: The Cheesecake Factory (NASDAQ:CAKE) And Sit-Down Dining Stocks In Q3
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the sit-down dining stocks, including The Cheesecake Factory (NASDAQ:CAKE) and its peers.
Via StockStory · November 20, 2025
Real Estate Services Stocks Q3 Highlights: RE/MAX (NYSE:RMAX)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how real estate services stocks fared in Q3, starting with RE/MAX (NYSE:RMAX).
Via StockStory · November 20, 2025
Senior Health, Home Health & Hospice Stocks Q3 Highlights: Chemed (NYSE:CHE)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how senior health, home health & hospice stocks fared in Q3, starting with Chemed (NYSE:CHE).
Via StockStory · November 20, 2025
Business Process Outsourcing & Consulting Stocks Q3 Recap: Benchmarking FTI Consulting (NYSE:FCN)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how business process outsourcing & consulting stocks fared in Q3, starting with FTI Consulting (NYSE:FCN).
Via StockStory · November 20, 2025
Q3 Rundown: Coty (NYSE:COTY) Vs Other Personal Care Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Coty (NYSE:COTY) and the best and worst performers in the personal care industry.
Via StockStory · November 20, 2025
Reflecting On Beverages, Alcohol, and Tobacco Stocks’ Q2 Earnings: Boston Beer (NYSE:SAM)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at beverages, alcohol, and tobacco stocks, starting with Boston Beer (NYSE:SAM).
Via StockStory · November 20, 2025
Q3 Earnings Roundup: ASGN (NYSE:ASGN) And The Rest Of The IT Services & Consulting Segment
Let’s dig into the relative performance of ASGN (NYSE:ASGN) and its peers as we unravel the now-completed Q3 it services & consulting earnings season.
Via StockStory · November 20, 2025
Sit-Down Dining Stocks Q3 In Review: First Watch (NASDAQ:FWRG) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at First Watch (NASDAQ:FWRG) and its peers.
Via StockStory · November 20, 2025
A Look Back at Thrifts & Mortgage Finance Stocks’ Q3 Earnings: AGNC Investment (NASDAQ:AGNC) Vs The Rest Of The Pack
Let’s dig into the relative performance of AGNC Investment (NASDAQ:AGNC) and its peers as we unravel the now-completed Q3 thrifts & mortgage finance earnings season.
Via StockStory · November 20, 2025
Design Software Stocks Q3 Earnings: Unity (NYSE:U) Best of the Bunch
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the design software industry, including Unity (NYSE:U) and its peers.
Via StockStory · November 20, 2025
Life Insurance Stocks Q3 Recap: Benchmarking Corebridge Financial (NYSE:CRBG)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the life insurance stocks, including Corebridge Financial (NYSE:CRBG) and its peers.
Via StockStory · November 20, 2025
BV Q3 Deep Dive: Investments in Workforce and Fleet Aim to Reignite Growth
Landscaping service company BrightView (NYSE:BV) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 3.6% year on year to $702.8 million. The company’s full-year revenue guidance of $2.7 billion at the midpoint came in 1.7% below analysts’ estimates. Its non-GAAP profit of $0.27 per share was 14.7% below analysts’ consensus estimates.
Via StockStory · November 20, 2025
2 Large-Cap Stocks to Own for Decades and 1 We Brush Off
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Via StockStory · November 20, 2025
3 Low-Volatility Stocks That Concern Us
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Via StockStory · November 20, 2025
2 Profitable Stocks with Competitive Advantages and 1 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · November 20, 2025
3 Value Stocks with Questionable Fundamentals
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Via StockStory · November 20, 2025
1 Surging Stock with Solid Fundamentals and 2 We Brush Off
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Via StockStory · November 20, 2025
3 Value Stocks We Keep Off Our Radar
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Via StockStory · November 20, 2025
2 Unpopular Stocks That Should Get More Attention and 1 We Ignore
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · November 20, 2025
3 Profitable Stocks with Warning Signs
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Via StockStory · November 20, 2025
1 Value Stock on Our Buy List and 2 Facing Challenges
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Via StockStory · November 20, 2025
3 Consumer Stocks with Open Questions
Retailers are evolving to meet the expectations of modern, tech-savvy shoppers. But many seem to be moving too slowly as their demand is lagging, causing the industry to underperform the market - over the past six months, retail stocks have shed 3.7%. This drawdown is a noticeable divergence from the S&P 500’s 10.1% return.
Via StockStory · November 20, 2025
1 Mid-Cap Stock Worth Investigating and 2 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Via StockStory · November 20, 2025
3 Consumer Stocks We Steer Clear Of
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted recently. Over the past six months, the industry has recorded a loss of 13.5%, a far cry from the S&P 500’s 10.1% ascent.
Via StockStory · November 20, 2025
Dynatrace, The Trade Desk, and Confluent Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory · November 20, 2025
Doximity, SentinelOne, Asure Software, Workday, and Bandwidth Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory · November 20, 2025
Petco, Sleep Number, Monro, MarineMax, and Abercrombie and Fitch Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory · November 20, 2025
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory · November 20, 2025